Al Machot, E., Hoffmann, T., Lorenz, K., Khalili, I., & Noack, B. (2014). Clinical Outcomes after Treatment of Periodontal Intrabony Defects with Nanocrystalline Hydroxyapatite (Ostim) or Enamel Matrix Derivatives (Emdogain): A Randomized Controlled Clinical Trial. Hindawi Publishing Corporation.
استشهاد بنمط شيكاغوAl Machot, Elyan, Thomas Hoffmann, Katrin Lorenz, Ihssan Khalili, و Barbara Noack. Clinical Outcomes After Treatment of Periodontal Intrabony Defects With Nanocrystalline Hydroxyapatite (Ostim) or Enamel Matrix Derivatives (Emdogain): A Randomized Controlled Clinical Trial. Hindawi Publishing Corporation, 2014.
MLA استشهادAl Machot, Elyan, et al. Clinical Outcomes After Treatment of Periodontal Intrabony Defects With Nanocrystalline Hydroxyapatite (Ostim) or Enamel Matrix Derivatives (Emdogain): A Randomized Controlled Clinical Trial. Hindawi Publishing Corporation, 2014.